Obesity Treatment Market Share

The global Obesity Treatment Market Share is growing with a swift phase; mainly due to increase in patient population and research and development done by market players to fill the gap of market. According to World Health Organization (WHO), the worldwide prevalence of obesity nearly doubled between 1980 and 2008. According to country estimates for 2008, over 50% of both men and women in the WHO European Region were overweight, and roughly 23% of women and 20% of men were obese. It is the cause of many health problems, such as obesity, heart disease, and certain cancers. Obesity leads to short- and long-term health problems for mother and her child, if she is excess weight during pregnancy.

Companies are continuously engaged in research and development process along with well know research institute for developing the best treatment of obesity and leads the market. In 2015, researchers at the University of Liverpool, working with a global health care company, have helped introduce a new treatment for obesity. After conducting the research it was found that the treatment which is a once-daily injectable derivative of a metabolic hormone called GLP-1 normally used in the type 2 obesity treatment, has proved that it help non diabetic patients in weight loss. These development help company to provide the best option for the treatment and capture the maximum share of global market.

Major Key Players:

Pfizer Inc. (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), AstraZeneca plc (U.K), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of Obesity Management, globally.

Segmental Analysis

The global obesity management market has been segmented on the basis of lifestyle changes, prescription weight-loss medication, surgery, and lastly region. Based on lifestyle changes, this market has been segmented into dietary changes, exercise, and others. Prescription weight-loss medication based segmentation segments the market into buproprion & naltrexone (Contrave), lorcaserin (Belviq), orlistat (Xenical), phentermine & topiramate (Qsymia), liraglutide (Saxenda), and others. On the basis of medical treatment for obesity, the market has been segmented into pediatric obesity , biliopancreatic diversion with duodenal switch, gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), and others.

Regional Analysis

The market of obesity management is growing rapidly in Asia Pacific region, owing to poor diet, lack of physical activity, and unhealthy life balance. These are the factor which leads the obesity population in this region. Most of the countries of this region have common lifestyle and economic conditions, So the factor introduce above have common with in this region and leads the patient population. Government of developing countries within this region are more focusing towards new technology and advance treatment option, thus more research and development programs are initiated for the development of new drugs.  These are the factors which are fuelling the growth of the market of obesity managements with the significant rates. These advance treatment will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. The market of obesity management is much higher in the Americas region attribute to high presence of obesity population along with developed treatment option. According to CDC, 37.9% of adults over 20 years were suffering with the obesity between 2013 and 2014 and 70.7% of adults aged 20 years and over were suffering with overweight, including obesity. These stats show the opportunity of market players within the Americas region.

 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]